R. Siegel, D. Naishadham, and A. Jemal, Cancer statistics, 2013, CA: A Cancer Journal for Clinicians, vol.287, issue.suppl 5, pp.11-30, 2013.
DOI : 10.1001/jama.287.16.2106

Y. Loriot, C. Massard, and K. Fizazi, Recent developments in treatments targeting castration-resistant prostate cancer bone metastases, Annals of Oncology, vol.23, issue.5, pp.1085-94, 2012.
DOI : 10.1093/annonc/mdr573

A. Armstrong, New Treatments for Men with Castration-resistant Prostate Cancer: Can We Move from Small Steps to Giant Leaps?, European Urology, vol.65, issue.2, pp.300-302, 2014.
DOI : 10.1016/j.eururo.2013.08.059

M. Lange, O. Rigal, C. B. , G. B. Sevin, E. Barillet et al., Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists, Cancer Treatment Reviews, vol.40, issue.6, pp.810-817, 2014.
DOI : 10.1016/j.ctrv.2014.03.003

F. Eustache and F. Joly, Baseline cognitive functions among elderly patients with localised breast cancer, Eur J Cancer, vol.50, pp.2181-2190, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01067444

F. Joly, G. B. Rigal, O. De-ruiter, M. Small, B. Dubois et al., Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012, Journal of Pain and Symptom Management, vol.50, issue.6, pp.830-871, 2015.
DOI : 10.1016/j.jpainsymman.2015.06.019

J. Wefel, J. Vardy, T. Ahles, and S. Schagen, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, The Lancet Oncology, vol.12, issue.7, pp.703-711, 2011.
DOI : 10.1016/S1470-2045(10)70294-1

M. Dubois, N. Lapinte, V. Villier, C. Lecointre, V. Roy et al., Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: Role of glucose as adjuvant, Neuropharmacology, vol.79, pp.234-282, 2014.
DOI : 10.1016/j.neuropharm.2013.11.012

M. Lange, N. Heutte, O. Rigal, S. Noal, J. Kurtz et al., Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment, The Oncologist, vol.21, issue.11, pp.1337-1385, 2016.
DOI : 10.1634/theoncologist.2016-0014

URL : https://hal.archives-ouvertes.fr/inserm-01369848

C. Nelson, J. Lee, M. Gamboa, and A. Roth, Cognitive effects of hormone therapy in men with prostate cancer, Cancer, vol.1, issue.(6 pt 1), pp.1097-106, 2008.
DOI : 10.1111/j.1532-5415.1998.tb02713.x

H. Mcginty, K. Phillips, H. Jim, J. Cessna, Y. Asvat et al., Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis, Supportive Care in Cancer, vol.24, issue.8, pp.2271-80, 2014.
DOI : 10.1200/JCO.2006.07.8303

K. Donovan, L. Walker, R. Wassersug, L. Thompson, and J. Robinson, Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners, Cancer, vol.9, issue.suppl 5, pp.4286-99, 2015.
DOI : 10.1016/j.ecl.2011.05.002

M. Maggio, E. Dall-'aglio, F. Lauretani, C. Cattabiani, G. Ceresini et al., The hormonal pathway to cognitive impairment in older men, The journal of nutrition, health & aging, vol.167, issue.3, pp.40-54, 2012.
DOI : 10.1001/archinte.167.20.2249

S. Moffat, A. Zonderman, E. Metter, M. Blackman, S. Harman et al., Longitudinal Assessment of Serum Free Testosterone Concentration Predicts Memory Performance and Cognitive Status in Elderly Men, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.11, pp.5001-5008, 2002.
DOI : 10.1210/jc.2002-020419

P. Thilers, S. Macdonald, and A. Herlitz, The association between endogenous free testosterone and cognitive performance: A population-based study in 35 to 90 year-oldmen and women, Psychoneuroendocrinology, vol.31, issue.5, pp.565-76, 2006.
DOI : 10.1016/j.psyneuen.2005.12.005

K. Young and S. Preskorn, Neuroscientific Basis of Corticosteroid-Induced Changes in Human Cognitive and Emotional Processing, Journal of Psychiatric Practice, vol.19, issue.4, pp.309-324, 2013.
DOI : 10.1097/01.pra.0000432601.09514.12

S. Fuller, R. Tan, and R. Martins, Androgens in the Etiology of Alzheimer's Disease in Aging Men and Possible Therapeutic Interventions, Journal of Alzheimer's Disease, vol.12, issue.2, pp.129-171, 2007.
DOI : 10.3233/JAD-2007-12202

H. Scher, K. Fizazi, F. Saad, M. Taplin, C. Sternberg et al., Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy, New England Journal of Medicine, vol.367, issue.13, pp.1187-97, 2012.
DOI : 10.1056/NEJMoa1207506

C. Leranth, O. Petnehazy, and N. Maclusky, Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats, J Neurosci, vol.23, issue.5, pp.1588-92, 2003.

T. Hajszan, N. Maclusky, J. Johansen, C. Jordan, and C. Leranth, Effects of Androgens and Estradiol on Spine Synapse Formation in the Prefrontal Cortex of Normal and Testicular Feminization Mutant Male Rats, Endocrinology, vol.148, issue.5, pp.1963-1970, 2007.
DOI : 10.1210/en.2006-1626

K. Raskin, K. De-gendt, A. Duittoz, P. Liere, G. Verhoeven et al., Conditional Inactivation of Androgen Receptor Gene in the Nervous System: Effects on Male Behavioral and Neuroendocrine Responses, Journal of Neuroscience, vol.29, issue.14, pp.4461-70, 2009.
DOI : 10.1523/JNEUROSCI.0296-09.2009

C. Fung, W. Dale, and S. Mohile, Prostate Cancer in the Elderly Patient, Journal of Clinical Oncology, vol.32, issue.24, pp.2523-2553, 2014.
DOI : 10.1200/JCO.2014.55.1531

K. Agrawal, S. Onami, J. Mortimer, and S. Pal, Cognitive changes associated with endocrine therapy for breast cancer, Maturitas, vol.67, issue.3, pp.209-223, 2010.
DOI : 10.1016/j.maturitas.2010.07.004

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253817

Z. Nasreddine, N. Phillips, V. Bedirian, S. Charbonneau, V. Whitehead et al., The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment, Journal of the American Geriatrics Society, vol.48, issue.4, pp.695-704, 2005.
DOI : 10.1212/WNL.52.2.231

A. Rey, Manual of copy and memory reproduction test of complexe geometric figures. Paris: Éditions Centre de psychologie appliquée, 1959.

I. Herrera-guzman, J. Pena-casanova, J. Lara, E. Gudayol-ferre, and P. Bohm, Influence of Age, Sex, and Education on the Visual Object and Space Perception Battery (VOSP) In a Healthy Normal Elderly Population, The Clinical Neuropsychologist, vol.13, issue.3, pp.385-94, 2004.
DOI : 10.1037/0033-2909.117.2.250

M. Van-der-linden, S. Adam, A. Agniel, C. Ntérion-thomas, C. Baisset-mouly et al., Assessment of memory impairment. Marseille: Solal, 2004.

A. Baddeley, H. Esmlie, and I. Nimmo-smith, The doors and people test, 2006.

D. Wechsler, Wechsler Adult Intelligence Scale-III]. Paris: ECPA, 2000.

R. Reitan, Validity of the Trail Making Test as an Indicator of Organic Brain Damage, Perceptual and Motor Skills, vol.73, issue.1, pp.271-277, 1958.
DOI : 10.1037/h0044509

D. Cardebat, B. Doyon, M. Puel, P. Goulet, and Y. Joanette, Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level, Acta Neurol Belg, vol.90, issue.4, pp.207-224, 1990.

C. Moroni and S. Bayard, Inhibitory process: what evolution after the age of 50?, Psychol Neuropsychiatr Vieil, vol.7, issue.1, pp.1-9, 2009.

H. Nelson, O. Connell, and A. , Dementia: The Estimation of Premorbid Intelligence Levels Using the New Adult Reading Test, Cortex, vol.14, issue.2, pp.234-278, 1978.
DOI : 10.1016/S0010-9452(78)80049-5

D. Cella, D. Tulsky, G. Gray, B. Sarafian, E. Linn et al., The Functional Assessment of Cancer Therapy scale: development and validation of the general measure., Journal of Clinical Oncology, vol.11, issue.3, pp.570-579, 1993.
DOI : 10.1200/JCO.1993.11.3.570

S. Yellen, D. Cella, K. Webster, C. Blendowski, and E. Kaplan, Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system, Journal of Pain and Symptom Management, vol.13, issue.2, pp.63-74, 1997.
DOI : 10.1016/S0885-3924(96)00274-6

D. Cella, M. Nichol, D. Eton, J. Nelson, and P. Mulani, Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy???Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer, Value in Health, vol.12, issue.1, pp.124-133, 2009.
DOI : 10.1111/j.1524-4733.2008.00409.x

F. Joly, M. Lange, O. Rigal, H. Correia, G. B. Beaumont et al., French version of the Functional Assessment of Cancer Therapy???Cognitive Function (FACT-Cog) version 3, Supportive Care in Cancer, vol.22, issue.12, pp.3297-305, 2012.
DOI : 10.1200/JCO.2004.08.094

D. Razavi, N. Delvaux, C. Farvacques, and E. Robaye, Screening for adjustment disorders and major depressive disorders in cancer in-patients, The British Journal of Psychiatry, vol.156, issue.1, pp.79-83, 1990.
DOI : 10.1192/bjp.156.1.79

C. Gagnon, L. Belanger, H. Ivers, and C. Morin, Validation of the Insomnia Severity Index in Primary Care, The Journal of the American Board of Family Medicine, vol.26, issue.6, pp.701-711, 2013.
DOI : 10.3122/jabfm.2013.06.130064

D. Morisky, A. Ang, M. Krousel-wood, and H. Ward, Predictive Validity of a Medication Adherence Measure in an Outpatient Setting, The Journal of Clinical Hypertension, vol.17, issue.3, pp.348-54, 2008.
DOI : 10.1177/109019819001700303

X. Girerd, O. Hanon, K. Anagnostopoulos, C. Ciupek, J. Mourad et al., Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic, Presse Med, vol.30, issue.21, pp.1044-1052, 2001.

P. Soubeyran, C. Bellera, J. Goyard, D. Heitz, H. Cure et al., Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study, PLoS ONE, vol.49, issue.12, p.115060, 2014.
DOI : 10.1371/journal.pone.0115060.s002

M. Charlson, P. Pompei, K. Ales, and C. Mackenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, Journal of Chronic Diseases, vol.40, issue.5, pp.373-83, 1987.
DOI : 10.1016/0021-9681(87)90171-8

S. Katz, T. Downs, H. Cash, and R. Grotz, Progress in Development of the Index of ADL, The Gerontologist, vol.10, issue.1 Part 1, pp.20-30, 1970.
DOI : 10.1093/geront/10.1_Part_1.20

M. Lawton and E. Brody, ASSESSMENT OF OLDER PEOPLE, Nursing Research, vol.19, issue.3, pp.179-86, 1969.
DOI : 10.1097/00006199-197005000-00029

Y. Guigoz, B. Vellas, and P. Garry, Assessing the Nutritional Status of the Elderly: The Mini Nutritional Assessment as Part of the Geriatric Evaluation, Nutrition Reviews, vol.54, issue.1, pp.59-65, 1996.
DOI : 10.1111/j.1753-4887.1996.tb03793.x

D. Podsiadlo and S. Richardson, The Timed ???Up & Go???: A Test of Basic Functional Mobility for Frail Elderly Persons, Journal of the American Geriatrics Society, vol.68, issue.2, pp.142-150, 1991.
DOI : 10.1007/978-1-4612-5232-0_10

A. Stewart, B. Collins, J. Mackenzie, E. Tomiak, S. Verma et al., The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study, Psycho-Oncology, vol.8, issue.2, pp.122-152, 2008.
DOI : 10.1053/scnp.2003.50002

A. Mcsweeney, R. Naugle, G. Chelune, and H. Lunders, Scores for Change???: An illustration of a regression approach to depicting change in clinical neuropsychology, Clinical Neuropsychologist, vol.13, issue.3, pp.300-312, 1993.
DOI : 10.1080/01688638108403128

S. Sawrie, D. Marson, A. Boothe, and L. Harrell, A Method for Assessing Clinically Relevant Individual Cognitive Change in Older Adult Populations, The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, vol.54, issue.2, pp.116-140, 1999.
DOI : 10.1093/geronb/54B.2.P116